Daily as of 3 Nov 16:00 ET
- Price
- above both $72.31 vs 50 $60.06 / 200 $51.18
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 7 Nov 2025 · projected 1 bar out
EXEL | ExelixisNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$72.31
+$2.18 (+3.11%)
Exelixis (EXEL) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.
The 50 SMA has sat above the 200 on the daily since Nov 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $69.39 vs 50 $49.81 / 200 $33.19
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 22 Jan 2024 · projected 29 bars out · tested 3 bars
4-hour as of 3 Nov 16:00 ET
- Price
- above both $72.31 vs 50 $62.94 / 200 $57.18
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 21 Apr 2026 · projected 20 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 21 Apr 2026 | 🟨Golden | 4-hour | 20 bars out | Not tested |
| 18 Mar 2026 | 💀Death | 4-hour | 17 bars out | Not tested |
| 21 Nov 2025 | 🟨Golden | 4-hour | 24 bars out | Not tested |
| 7 Nov 2025 | 🟨Golden flat | daily | 1 bar out | Not tested |
| 22 Oct 2025 | 💀Death flat | daily | 2 bars out | 4 bar cross test |
About EXEL
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$120M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandlarge